You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 4, October 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (61)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Anemia, Cataracts, and Seizures in Patient With Glucose-6-Phosphate Dehydrogenase Deficiency

DAVID W. WESTRING, MD; ANTHONY V. PISCIOTTA, MD

Arch Intern Med. 1966;118(4):385-390.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

CONGENITAL CONGENITAL nonspherocytic hemolytic anemia is a heterogenous group of hemolytic disorders characterized by disturbances of glycolytic metabolism in the erythrocyte. One category has been associated with defects in the Embden-Meyerhof pathway of glucose metabolism; patients with erythrocytes defective in pyruvate kinase 1 and triose phosphate isomerase2 activity have been described. Another group has been associated with diminished glucose-6-phosphate dehydrogenase (G-6-PD) activity. This abnormality results in an inability to generate reduced triphosphopyridine nucleotide (TPNH) in the hexose monophosphate shunt.

Deficient erythrocyte G-6-PD activity is associated with a number of hemolytic diseases of variable severity. In some cases, red cells deficient in this enzyme activity do not ordinarily hemolyze unless the patient is exposed to certain oxidizing drugs, such as primaquine.3 This manifestation occurs in 10% to 15% of American Negro men as a sex-linked recessive trait. On the other hand, most affected Caucasians show almost constant hemolysis. Because . . . [Full Text PDF of this Article]


Author Affiliations

MILWAUKEE

From the Department of Medicine, Marquette University School of Medicine, and Blood Research Laboratory, Milwaukee County General Hospital, Milwaukee. Dr. Westring is presently with the Department of Medicine, University of Wisconsin Medical School, Madison, Wis.


Footnotes

Received for publication May 10, 1966; accepted July 25.

Reprint requests to the Department of Medicine, University Hospitals, 1300 University Ave, Madison, Wis 53706 (Dr. Westring).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.